Giulio Pierleoni

Siena, 53100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

CuInP2S6 Captures Virus for Viral Inhibition and Vaccine Adjuvanticity.

CuInP2S6 Captures Virus for Viral Inhibition and Vaccine Adjuvanticity.

Journal: Nano letters
Published: March 20, 2026

Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID-19 Booster Vaccination-A Population-Based Study of 3066 Individuals.

Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID-19 Booster Vaccination-A Population-Based Study of 3066 Individuals.

Journal: Influenza and other respiratory viruses
Published: February 19, 2026

Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153.

Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153.

Journal: Science translational medicine
Published: December 10, 2025

State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens.

State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens.

Journal: Seminars in respiratory and critical care medicine
Published: January 27, 2025

State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens.

State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens.

Journal: Seminars in respiratory and critical care medicine
Published: January 27, 2025

SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines.

SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines.

Journal: Science immunology
Published: August 09, 2024

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Journal: Cell reports
Published: April 29, 2024

Discovery and characterization of a pan-betacoronavirus S2-binding antibody.

Discovery and characterization of a pan-betacoronavirus S2-binding antibody.

Journal: Structure (London, England : 1993)
Published: February 05, 2024

Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody.

Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody.

Journal: bioRxiv : the preprint server for biology
Published: January 31, 2024

Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.

Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: March 09, 2023

mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5.

mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5.

Journal: Nature communications
Published: August 04, 2022

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response.

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response.

Journal: Nature communications
Published: May 25, 2022
Showing 1-12 of 14

Last Updated: 09/26/2026